This article is cited by 218 publications.

1. Yan A. Ivanenkov, Bogdan A. Zagribelnyy, Vladimir A. Aladinskiy. Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?. Journal of Medicinal Chemistry 2019, 62 (22) , 10026-10043. DOI: 10.1021/acs.jmedchem.9b00004.
2. Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, Peng Zhan. Overview of Recent Strategic Advances in Medicinal Chemistry. Journal of Medicinal Chemistry 2019, 62 (21) , 9375-9414. DOI: 10.1021/acs.jmedchem.9b00359.
3. Brian Cox, Kevin I. Booker-Milburn, Luke D. Elliott, Michael Robertson-Ralph, Victor Zdorichenko. Escaping from Flatland: [2 + 2] Photocycloaddition; Conformationally Constrained sp3-rich Scaffolds for Lead Generation. ACS Medicinal Chemistry Letters 2019, 10 (11) , 1512-1517. DOI: 10.1021/acsmedchemlett.9b00409.
4. Alan H. Lipkus, Steven P. Watkins, Keith Gengras, Matthew J. McBride, Todd J. Wills. Recent Changes in the Scaffold Diversity of Organic Chemistry As Seen in the CAS Registry. The Journal of Organic Chemistry 2019, 84 (21) , 13948-13956. DOI: 10.1021/acs.joc.9b02111.
5. Guotong Wang, Pengcheng Cui, Hongjin Bai, Sanyue Wei, Shengkun Li. Late-Stage C–H Functionalization of Nicotinamides for the Expedient Discovery of Novel Antifungal Leads. Journal of Agricultural and Food Chemistry 2019, 67 (43) , 11901-11910. DOI: 10.1021/acs.jafc.9b05349.
6. Matteo Faltracco, Silvia Cotogno, Christophe M. L. Vande Velde, Eelco Ruijter. Catalytic Asymmetric Synthesis of Diketopiperazines by Intramolecular Tsuji–Trost Allylation. The Journal of Organic Chemistry 2019, 84 (18) , 12058-12070. DOI: 10.1021/acs.joc.9b01994.
7. Maxwell D. Cummings, Sivakumar Sekharan. Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. Journal of Medicinal Chemistry 2019, 62 (15) , 6843-6853. DOI: 10.1021/acs.jmedchem.8b01985.
8. Leijie Zhou, Chunhao Yuan, Yuan Zeng, Qijun Wang, Chang Wang, Min Liu, Wei Wang, Yongjun Wu, Bing Zheng, Hongchao Guo. Direct Activation of Unmodified Morita–Baylis–Hillman Alcohols through Phosphine Catalysis for Rapid Construction of Three-Dimensional Heterocyclic Compounds. Organic Letters 2019, 21 (12) , 4882-4886. DOI: 10.1021/acs.orglett.9b01783.
9. Irini Abdiaj, Clemens R. Horn, Jesus Alcazar. Scalability of Visible-Light-Induced Nickel Negishi Reactions: A Combination of Flow Photochemistry, Use of Solid Reagents, and In-Line NMR Monitoring. The Journal of Organic Chemistry 2019, 84 (8) , 4748-4753. DOI: 10.1021/acs.joc.8b02358.
10. Seb Caille, Sheng Cui, Margaret M. Faul, Steven M. Mennen, Jason S. Tedrow, Shawn D. Walker. Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry. The Journal of Organic Chemistry 2019, 84 (8) , 4583-4603. DOI: 10.1021/acs.joc.9b00735.
11. Alan H. Cherney, Simon J. Hedley, Steven M. Mennen, Jason S. Tedrow. Xantphos as a Branch-Selective Ligand for the Acyclic sec-Alkyl Negishi Cross-Coupling of Heteroaryl Halides. Organometallics 2019, 38 (1) , 97-102. DOI: 10.1021/acs.organomet.8b00590.
12. Shuming Chen, Amy Y. Chan, Morgan M. Walker, Jonathan A. Ellman, K. N. Houk. π-Facial Selectivities in Hydride Reductions of Hindered Endocyclic Iminium Ions. The Journal of Organic Chemistry 2019, 84 (1) , 273-281. DOI: 10.1021/acs.joc.8b02603.
13. Brian Raymer, Samit K. Bhattacharya. Lead-like Drugs: A Perspective. Journal of Medicinal Chemistry 2018, 61 (23) , 10375-10384. DOI: 10.1021/acs.jmedchem.8b00407.
14. Allan M. Jordan. Artificial Intelligence in Drug Design—The Storm Before the Calm?. ACS Medicinal Chemistry Letters 2018, 9 (12) , 1150-1152. DOI: 10.1021/acsmedchemlett.8b00500.
15. Denis N. Prada Gori, Caterina Permingeat Squizatto, Patricia G. Cornier, Carina M. L. Delpiccolo. Design of a Selective Ring-Closing Enyne Metathesis–Reduction for the Generation of Different Synthetic Scaffolds. The Journal of Organic Chemistry 2018, 83 (20) , 12798-12805. DOI: 10.1021/acs.joc.8b01511.
16. Noah B. Bissonnette, Michael J. Boyd, Gregory D. May, Simon Giroux, Philippe Nuhant. C–H Functionalization of Heteroarenes Using Unactivated Alkyl Halides through Visible-Light Photoredox Catalysis under Basic Conditions. The Journal of Organic Chemistry 2018, 83 (18) , 10933-10940. DOI: 10.1021/acs.joc.8b01589.
17. David A. DeGoey, Hui-Ju Chen, Philip B. Cox, Michael D. Wendt. Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection. Journal of Medicinal Chemistry 2018, 61 (7) , 2636-2651. DOI: 10.1021/acs.jmedchem.7b00717.
18. Phil S. Baran (JACS Associate Editor). Natural Product Total Synthesis: As Exciting as Ever and Here To Stay. Journal of the American Chemical Society 2018, 140 (14) , 4751-4755. DOI: 10.1021/jacs.8b02266.
19. Emily E. Robinson and Regan J. Thomson . A Strategy for the Convergent and Stereoselective Assembly of Polycyclic Molecules. Journal of the American Chemical Society 2018, 140 (5) , 1956-1965. DOI: 10.1021/jacs.7b13234.
20. Philip Lamers and Carsten Bolm . Tetrahydrobenzo[c]thieno[2,1-e]isothiazole 4-Oxides: Three-Dimensional Heterocycles as Cross-Coupling Building Blocks. Organic Letters 2018, 20 (1) , 116-118. DOI: 10.1021/acs.orglett.7b03475.
21. Petra Králová, Michal Maloň, and Miroslav Soural . Stereoselective Synthesis of Benzo[e][1,4]oxazino[4,3-a][1,4]diazepine-6,12-diones with Two Diversity Positions. ACS Combinatorial Science 2017, 19 (12) , 770-774. DOI: 10.1021/acscombsci.7b00134.
22. Jabrane Jouha, Floris Buttard, Magali Lorion, Clément Berthonneau, Mostafa Khouili, Marie-Aude Hiebel, Gérald Guillaumet, Jean-François Brière, and Franck Suzenet . Domino Aza-Michael-ih-Diels–Alder Reaction to Various 3-Vinyl-1,2,4-triazines: Access to Polysubstituted Tetrahydro-1,6-naphthyridines. Organic Letters 2017, 19 (18) , 4770-4773. DOI: 10.1021/acs.orglett.7b02132.
23. Shiao Y. Chow and Adam Nelson . Embarking on a Chemical Space Odyssey. Journal of Medicinal Chemistry 2017, 60 (9) , 3591-3593. DOI: 10.1021/acs.jmedchem.7b00423.
24. Manish Sud . MayaChemTools: An Open Source Package for Computational Drug Discovery. Journal of Chemical Information and Modeling 2016, 56 (12) , 2292-2297. DOI: 10.1021/acs.jcim.6b00505.
25. Andreas Gollner, Dorothea Rudolph, Heribert Arnhof, Markus Bauer, Sophia M. Blake, Guido Boehmelt, Xiao-Ling Cockroft, Georg Dahmann, Peter Ettmayer, Thomas Gerstberger, Jale Karolyi-Oezguer, Dirk Kessler, Christiane Kofink, Juergen Ramharter, Jörg Rinnenthal, Alexander Savchenko, Renate Schnitzer, Harald Weinstabl, Ulrike Weyer-Czernilofsky, Tobias Wunberg, and Darryl B. McConnell . Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction. Journal of Medicinal Chemistry 2016, 59 (22) , 10147-10162. DOI: 10.1021/acs.jmedchem.6b00900.
26. Eva Schütznerová, Pedro Verdía, and Viktor Krchňák . Fused Ring Molecular Scaffold with 3D Architecture for Constrained Peptidomimetics: Polymer-Supported Stereoselective Synthesis of Tetrahydrobenzo[e]pyrazino[2,1-c][1,2,4]thiadiazinone 6,6-dioxide via N-Acyl Iminiums. ACS Combinatorial Science 2016, 18 (10) , 655-659. DOI: 10.1021/acscombsci.6b00126.
27. Yu-Wen Huang and Alison J. Frontier . Nazarov Cyclization/Internal Redox Cyclization Sequence for the Synthesis of N-Heterocyclic Bridged Ring Systems. Organic Letters 2016, 18 (19) , 4896-4899. DOI: 10.1021/acs.orglett.6b02369.
28. Pedro Luis Arrechea and Stephen L. Buchwald . Biaryl Phosphine Based Pd(II) Amido Complexes: The Effect of Ligand Structure on Reductive Elimination. Journal of the American Chemical Society 2016, 138 (38) , 12486-12493. DOI: 10.1021/jacs.6b05990.
29. Laura N. Poloni, Anthony P. Ford, and Michael D. Ward . Site Discrimination and Anisotropic Growth Inhibition by Molecular Imposters on Highly Dissymmetric Crystal Surfaces. Crystal Growth & Design 2016, 16 (9) , 5525-5541. DOI: 10.1021/acs.cgd.6b01013.
30. Dean G. Brown and Jonas Boström . Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?. Journal of Medicinal Chemistry 2016, 59 (10) , 4443-4458. DOI: 10.1021/acs.jmedchem.5b01409.
31. Nadine Schneider, Daniel M. Lowe, Roger A. Sayle, Michael A. Tarselli, and Gregory A. Landrum . Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists’ Bread and Butter. Journal of Medicinal Chemistry 2016, 59 (9) , 4385-4402. DOI: 10.1021/acs.jmedchem.6b00153.
32. Tuomo Kalliokoski . Price-Focused Analysis of Commercially Available Building Blocks for Combinatorial Library Synthesis. ACS Combinatorial Science 2015, 17 (10) , 600-607. DOI: 10.1021/acscombsci.5b00063.
33. Shuming Chen, Brandon Q. Mercado, Robert G. Bergman, and Jonathan A. Ellman . Regio- and Diastereoselective Synthesis of Highly Substituted, Oxygenated Piperidines from Tetrahydropyridines. The Journal of Organic Chemistry 2015, 80 (13) , 6660-6668. DOI: 10.1021/acs.joc.5b00816.
34. David Camp, Agatha Garavelas, and Marc Campitelli . Analysis of Physicochemical Properties for Drugs of Natural Origin. Journal of Natural Products 2015, 78 (6) , 1370-1382. DOI: 10.1021/acs.jnatprod.5b00255.
35. Kohei Matsuzaki, Kenta Okuyama, Etsuko Tokunaga, Norimichi Saito, Motoo Shiro, and Norio Shibata . Synthesis of Diaryliodonium Salts Having Pentafluorosulfanylarenes and Their Application to Electrophilic Pentafluorosulfanylarylation of C-, O-, N-, and S-Nucleophiles. Organic Letters 2015, 17 (12) , 3038-3041. DOI: 10.1021/acs.orglett.5b01323.
36. Luciana Méndez and Ernesto G. Mata . Solid-Supported Cross-Metathesis and a Formal Alkane Metathesis for the Generation of Biologically Relevant Molecules. ACS Combinatorial Science 2015, 17 (2) , 81-86. DOI: 10.1021/co500176b.
37. Megan H. Shaw, Niall G. McCreanor, William G. Whittingham, and John F. Bower . Reversible C–C Bond Activation Enables Stereocontrol in Rh-Catalyzed Carbonylative Cycloadditions of Aminocyclopropanes. Journal of the American Chemical Society 2015, 137 (1) , 463-468. DOI: 10.1021/ja511335v.
38. Jinglan Zhou, Erica L. Campbell-Conroy, Alina Silina, Johnny Uy, Fabrice Pierre, Dennis J. Hurley, Nicole Hilgraf, Bryan A. Frieman, and Michael P. DeNinno . Synthesis of Fused Bicyclic Piperidines: Potential Bioactive Templates for Medicinal Chemistry. The Journal of Organic Chemistry 2015, 80 (1) , 70-79. DOI: 10.1021/jo501967m.
39. Janek Szychowski, Jean-François Truchon, and Youssef L. Bennani . Natural Products in Medicine: Transformational Outcome of Synthetic Chemistry. Journal of Medicinal Chemistry 2014, 57 (22) , 9292-9308. DOI: 10.1021/jm500941m.
40. Rohan R. Merchant, Daniel M. Allwood, David C. Blakemore, and Steven V. Ley . Regioselective Preparation of Saturated Spirocyclic and Ring-Expanded Fused Pyrazoles. The Journal of Organic Chemistry 2014, 79 (18) , 8800-8811. DOI: 10.1021/jo501624t.
41. Tehetena Mesganaw and Jonathan A. Ellman . Convergent Synthesis of Diverse Tetrahydropyridines via Rh(I)-Catalyzed C–H Functionalization Sequences. Organic Process Research & Development 2014, 18 (9) , 1097-1104. DOI: 10.1021/op500224x.
42. Richard D. Taylor, Malcolm MacCoss, and Alastair D. G. Lawson . Rings in Drugs. Journal of Medicinal Chemistry 2014, 57 (14) , 5845-5859. DOI: 10.1021/jm4017625.
43. Naděžda Cankařová, Agustina La Venia, and Viktor Krchňák . Polymer-Supported Stereoselective Synthesis of Tetrahydrobenzopyrazino-thiadiazinone Dioxides via N-Sulfonyl Iminiums. ACS Combinatorial Science 2014, 16 (6) , 293-302. DOI: 10.1021/co5000163.
44. Makonen Belema, Van N. Nguyen, Jeffrey L. Romine, Denis R. St. Laurent, Omar D. Lopez, Jason T. Goodrich, Peter T. Nower, Donald R. O’Boyle, II, Julie A. Lemm, Robert A. Fridell, Min Gao, Hua Fang, Rudolph G. Krause, Ying-Kai Wang, A. Jayne Oliver, Andrew C. Good, Jay O. Knipe, Nicholas A. Meanwell, and Lawrence B. Snyder . Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons. Journal of Medicinal Chemistry 2014, 57 (5) , 1995-2012. DOI: 10.1021/jm4016203.
45. Kentaro Kawai, Naoya Nagata, and Yoshimasa Takahashi . De Novo Design of Drug-Like Molecules by a Fragment-Based Molecular Evolutionary Approach. Journal of Chemical Information and Modeling 2014, 54 (1) , 49-56. DOI: 10.1021/ci400418c.
46. Anat Levit, Thijs Beuming, Goran Krilov, Woody Sherman, and Masha Y. Niv . Predicting GPCR Promiscuity Using Binding Site Features. Journal of Chemical Information and Modeling 2014, 54 (1) , 184-194. DOI: 10.1021/ci400552z.
47. Daniel M. Allwood, David C. Blakemore, Alan D. Brown, and Steven V. Ley . Metal-Free Coupling of Saturated Heterocyclic Sulfonylhydrazones with Boronic Acids. The Journal of Organic Chemistry 2014, 79 (1) , 328-338. DOI: 10.1021/jo402526z.
48. Nicholas J. Race and John F. Bower . Palladium Catalyzed Cyclizations of Oxime Esters with 1,2-Disubstituted Alkenes: Synthesis of Dihydropyrroles. Organic Letters 2013, 15 (17) , 4616-4619. DOI: 10.1021/ol4023112.
49. Takashi Tsukamoto . Tough Times for Medicinal Chemists: Are We to Blame?. ACS Medicinal Chemistry Letters 2013, 4 (4) , 369-370. DOI: 10.1021/ml400074k.
50. Megan H. Shaw, Ekaterina Y. Melikhova, Daniel P. Kloer, William G. Whittingham, and John F. Bower . Directing Group Enhanced Carbonylative Ring Expansions of Amino-Substituted Cyclopropanes: Rhodium-Catalyzed Multicomponent Synthesis of N-Heterobicyclic Enones. Journal of the American Chemical Society 2013, 135 (13) , 4992-4995. DOI: 10.1021/ja401936c.
51. Ákos Tarcsay and György M. Keserű . Contributions of Molecular Properties to Drug Promiscuity. Journal of Medicinal Chemistry 2013, 56 (5) , 1789-1795. DOI: 10.1021/jm301514n.
52. Agustina La Venia, Bohumil Dolenský, and Viktor Krchňák . Polymer-Supported Stereoselective Synthesis of Tetrahydro-2H-oxazolo[3,2-a]pyrazin-5(3H)-ones from N-(2-Oxo-ethyl)-Derivatized Dipeptides via Eastbound Iminiums. ACS Combinatorial Science 2013, 15 (3) , 162-167. DOI: 10.1021/co3001567.
53. Elisabeth Christiansen, Maria E. Due-Hansen, Christian Urban, Manuel Grundmann, Johannes Schmidt, Steffen V. F. Hansen, Brian D. Hudson, Mohamed Zaibi, Stine B. Markussen, Ellen Hagesaether, Graeme Milligan, Michael A. Cawthorne, Evi Kostenis, Matthias U. Kassack, and Trond Ulven . Discovery of a Potent and Selective Free Fatty Acid Receptor 1 Agonist with Low Lipophilicity and High Oral Bioavailability. Journal of Medicinal Chemistry 2013, 56 (3) , 982-992. DOI: 10.1021/jm301470a.
54. Jonathan E. Grob, Michael A. Dechantsreiter, Ritesh B. Tichkule, Michael K. Connolly, Ayako Honda, Ronald C. Tomlinson, and Lawrence G. Hamann . One-Pot C–N/C–C Cross-Coupling of Methyliminodiacetic Acid Boronyl Arenes Enabled by Protective Enolization. Organic Letters 2012, 14 (21) , 5578-5581. DOI: 10.1021/ol302702q.
55. Alfonso T. García-Sosa, Mare Oja, Csaba Hetényi, and Uko Maran . DrugLogit: Logistic Discrimination between Drugs and Nondrugs Including Disease-Specificity by Assigning Probabilities Based on Molecular Properties. Journal of Chemical Information and Modeling 2012, 52 (8) , 2165-2180. DOI: 10.1021/ci200587h.
56. Natalya I. Vasilevich, Roman V. Kombarov, Dmitry V. Genis, and Michael A. Kirpichenok . Lessons from Natural Products Chemistry Can Offer Novel Approaches for Synthetic Chemistry in Drug Discovery. Journal of Medicinal Chemistry 2012, 55 (16) , 7003-7009. DOI: 10.1021/jm300344v.
57. Elisabeth Christiansen, Maria E. Due-Hansen, Christian Urban, Manuel Grundmann, Ralf Schröder, Brian D. Hudson, Graeme Milligan, Michael A. Cawthorne, Evi Kostenis, Matthias U. Kassack, and Trond Ulven . Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonists: Mesylpropoxy Appendage Lowers Lipophilicity and Improves ADME Properties. Journal of Medicinal Chemistry 2012, 55 (14) , 6624-6628. DOI: 10.1021/jm3002026.
58. Naděžda Cankařová and Viktor Krchňák . Polymer-Supported Stereoselective Synthesis of Benzimidazolinopiperazinones. The Journal of Organic Chemistry 2012, 77 (13) , 5687-5695. DOI: 10.1021/jo300836c.
59. Adam J. Salmon, Michael L. Williams, Quoc K. Wu, Julia Morizzi, Daniel Gregg, Susan A. Charman, Daniela Vullo, Claudiu T. Supuran, and Sally-Ann Poulsen . Metallocene-Based Inhibitors of Cancer-Associated Carbonic Anhydrase Enzymes IX and XII. Journal of Medicinal Chemistry 2012, 55 (11) , 5506-5517. DOI: 10.1021/jm300427m.
60. Ákos Tarcsay, Kinga Nyíri, and György M. Keserű . Impact of Lipophilic Efficiency on Compound Quality. Journal of Medicinal Chemistry 2012, 55 (3) , 1252-1260. DOI: 10.1021/jm201388p.
61. Kentaro Kawai, Yukiko Karuo, Atsushi Tarui, Kazuyuki Sato, Masaaki Omote. Effect of Structural Descriptors on the Design of Cyclin Dependent Kinase Inhibitors Using Similarity‐based Molecular Evolution. Molecular Informatics 2020, DOI: 10.1002/minf.201900126.
62. Sonia Lobo. Is there enough focus on lipophilicity in drug discovery?. Expert Opinion on Drug Discovery 2019, 1824, 1-3. DOI: 10.1080/17460441.2020.1691995.
63. Guangqiang Xu, Li Zhou, Chengdong Lv, Mo Xian, Qinggang Wang. Metal- and acid-free, TBN-mediated direct C H nitration of arenes. Journal of Saudi Chemical Society 2019, 23 (7) , 896-902. DOI: 10.1016/j.jscs.2019.01.002.
64. Jaroslaw Polanski, Anna Pedrys, Roksana Duszkiewicz, Urszula Kucia. Ligand Potency, Efficiency and Drug-likeness: A Story of Intuition, Misinterpretation and Serendipity. Current Protein & Peptide Science 2019, 20 (11) , 1069-1076. DOI: 10.2174/1389203719666190527080832.
65. Shengzheng Wang, Guoqiang Dong, Chunquan Sheng. Structural simplification: an efficient strategy in lead optimization. Acta Pharmaceutica Sinica B 2019, 9 (5) , 880-901. DOI: 10.1016/j.apsb.2019.05.004.
66. Scott Rice, Daniel J. Cox, Stephen P. Marsden, Adam Nelson. Unified synthesis of diverse building blocks for application in the discovery of bioactive small molecules. Tetrahedron 2019, 75 (38) , 130513. DOI: 10.1016/j.tet.2019.130513.
67. Jere K. Mannisto, Aleksi Sahari, Kalle Lagerblom, Teemu Niemi, Martin Nieger, Gábor Sztanó, Timo Repo. One‐Step Synthesis of 3,4‐Disubstituted 2‐Oxazolidinones by Base‐Catalyzed CO 2 Fixation and Aza‐Michael Addition. Chemistry – A European Journal 2019, 25 (44) , 10284-10289. DOI: 10.1002/chem.201902451.
68. Hana Michnová, Šárka Pospíšilová, Tomáš Goněc, Iva Kapustíková, Peter Kollár, Violetta Kozik, Robert Musioł, Izabela Jendrzejewska, Ján Vančo, Zdeněk Trávníček, Alois Čížek, Andrzej Bąk, Josef Jampílek. Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides: Comparative Molecular Surface Analysis. Molecules 2019, 24 (16) , 2991. DOI: 10.3390/molecules24162991.
69. Jaroslaw Polanski, Andrzej Bak. Ligand potency – an essential estimator for drug design: between intuition, misinterpretation and serendipity. Future Medicinal Chemistry 2019, 11 (14) , 1827-1843. DOI: 10.4155/fmc-2018-0230.
70. Rong Zhang, Patrick J. McIntyre, Patrick M. Collins, Daniel J. Foley, Christopher Arter, Frank von Delft, Richard Bayliss, Stuart Warriner, Adam Nelson. Construction of a Shape‐Diverse Fragment Set: Design, Synthesis and Screen against Aurora‐A Kinase. Chemistry – A European Journal 2019, 25 (27) , 6831-6839. DOI: 10.1002/chem.201900815.
71. Elena Lenci, Andrea Trabocchi. Smart Design of Small‐Molecule Libraries: When Organic Synthesis Meets Cheminformatics. ChemBioChem 2019, 20 (9) , 1115-1123. DOI: 10.1002/cbic.201800751.
72. Anne‐Katrin Bachon, Alina Hermann, Carsten Bolm. 3D Heterocycles from Sulfonimidamides by Sequential C−H Bond Alkenylation/Aza‐Michael Cyclization. Chemistry – A European Journal 2019, 25 (23) , 5889-5892. DOI: 10.1002/chem.201900920.
73. Joan Mayol-Llinàs, Shiao Chow, Adam Nelson. Expansion of the structure–activity relationships of BACE1 inhibitors by harnessing diverse building blocks prepared using a unified synthetic approach. MedChemComm 2019, 10 (4) , 616-620. DOI: 10.1039/C9MD00085B.
74. Ahmed Al Otaibi, Fiona M. Deane, Cecilia C. Russell, Lacey Hizartzidis, Siobhann N. McCluskey, Jennette A. Sakoff, Adam McCluskey. A methanol and protic ionic liquid Ugi multicomponent reaction path to cytotoxic α-phenylacetamido amides. RSC Advances 2019, 9 (14) , 7652-7663. DOI: 10.1039/C9RA00118B.
75. Gisbert Schneider. Mind and machine in drug design. Nature Machine Intelligence 2019, 1 (3) , 128-130. DOI: 10.1038/s42256-019-0030-7.
76. Andreas Luxenburger, Dorian Schmidt, Chiara Ianes, Christian Pichlo, Marc Krüger, Thorsten von Drathen, Elena Brunstein, Graeme Gainsford, Ulrich Baumann, Uwe Knippschild, Christian Peifer. Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds. Molecules 2019, 24 (5) , 873. DOI: 10.3390/molecules24050873.
77. Si Zheng, Hetong Ma, Jiayang Wang, Jiao Li. A Computational Bipartite Graph-Based Drug Repurposing Method. 2019,,, 115-127. DOI: 10.1007/978-1-4939-8955-3_7.
78. Shinuk Kim. Pathway Interactions Based on Drug-Induced Datasets. Cancer Informatics 2019, 18, 117693511985151. DOI: 10.1177/1176935119851518.
79. Jonas Boström, Dean G. Brown, Robert J. Young, György M. Keserü. Expanding the medicinal chemistry synthetic toolbox. Nature Reviews Drug Discovery 2018, 17 (10) , 709-727. DOI: 10.1038/nrd.2018.116.
80. Thomas Flagstad, Carlos M. G. Azevedo, Geanna Min, Anthony Willaume, Rémy Morgentin, Thomas E. Nielsen, Mads H. Clausen. Petasis/Diels-Alder/Cyclization Cascade Reactions for the Generation of Scaffolds with Multiple Stereogenic Centers and Orthogonal Handles for Library Production. European Journal of Organic Chemistry 2018, 2018 (36) , 5023-5029. DOI: 10.1002/ejoc.201800565.
81. Hao Yu, Zhen Li, Carsten Bolm. Three-Dimensional Heterocycles by Iron-Catalyzed Ring-Closing Sulfoxide Imidation. Angewandte Chemie 2018, 130 (37) , 12229-12232. DOI: 10.1002/ange.201804284.
82. Hao Yu, Zhen Li, Carsten Bolm. Three-Dimensional Heterocycles by Iron-Catalyzed Ring-Closing Sulfoxide Imidation. Angewandte Chemie International Edition 2018, 57 (37) , 12053-12056. DOI: 10.1002/anie.201804284.
83. Peter J. Cossar, Cecilia C. Russell, Siobhann N. McCluskey, Dylan Pope, Paul V. Bernhardt, Adam McCluskey. Crystal Structure of Ethyl 2,4-Dimethyl-1-phenyl-6-thioxo-1,6-dihydropyrimidine-5-carboxylate: The Product from the Reaction of Ethyl 3-Aminocrotonate, Phenylisothiocyanate and Acetic Anhydride. Journal of Chemical Crystallography 2018, 48 (3) , 91-95. DOI: 10.1007/s10870-018-0714-6.
84. Ettore J. Rastelli, Andrew A. Bolinger, Don M. Coltart. Stereodivergent Synthesis of β,γ-Fused Bicyclic γ-Lactones via a Multicomponent Ring-Expansion Cascade. Chem 2018, 4 (9) , 2228-2238. DOI: 10.1016/j.chempr.2018.08.007.
85. Remy Morgentin, Mark Dow, Anthony Aimon, George Karageorgis, Tuomo Kalliokoski, Didier Roche, Stephen Marsden, Adam Nelson. Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory. Drug Discovery Today 2018, 23 (9) , 1578-1583. DOI: 10.1016/j.drudis.2018.05.007.
86. Shiao Chow, Samuel Liver, Adam Nelson. Streamlining bioactive molecular discovery through integration and automation. Nature Reviews Chemistry 2018, 2 (8) , 174-183. DOI: 10.1038/s41570-018-0025-7.
87. Irini Abdiaj, Alberto Fontana, M. Victoria Gomez, Antonio de la Hoz, Jesús Alcázar. Visible-Light-Induced Nickel-Catalyzed Negishi Cross-Couplings by Exogenous-Photosensitizer-Free Photocatalysis. Angewandte Chemie 2018, 130 (28) , 8609-8613. DOI: 10.1002/ange.201802656.
88. Irini Abdiaj, Alberto Fontana, M. Victoria Gomez, Antonio de la Hoz, Jesús Alcázar. Visible-Light-Induced Nickel-Catalyzed Negishi Cross-Couplings by Exogenous-Photosensitizer-Free Photocatalysis. Angewandte Chemie International Edition 2018, 57 (28) , 8473-8477. DOI: 10.1002/anie.201802656.
89. Mario P. Wiesenfeldt, Tobias Knecht, Christoph Schlepphorst, Frank Glorius. Silylarenhydrierung – ein strategischer Ansatz für einen direkten Zugang zu silylierten gesättigten Carbo‐ und Heterocyclen. Angewandte Chemie 2018, 130 (27) , 8429-8432. DOI: 10.1002/ange.201804124.
90. Mario P. Wiesenfeldt, Tobias Knecht, Christoph Schlepphorst, Frank Glorius. Silylarene Hydrogenation: A Strategic Approach that Enables Direct Access to Versatile Silylated Saturated Carbo- and Heterocycles. Angewandte Chemie International Edition 2018, 57 (27) , 8297-8300. DOI: 10.1002/anie.201804124.
91. Edward J. Griffen, Alexander G. Dossetter, Andrew G. Leach, Shane Montague. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?. Drug Discovery Today 2018, 23 (7) , 1373-1384. DOI: 10.1016/j.drudis.2018.03.011.
92. Yongseok Kwon, Alex J. Chinn, Byoungmoo Kim, Scott J. Miller. Divergent Control of Point and Axial Stereogenicity: Catalytic Enantioselective C−N Bond-Forming Cross-Coupling and Catalyst-Controlled Atroposelective Cyclodehydration. Angewandte Chemie 2018, 130 (21) , 6359-6363. DOI: 10.1002/ange.201802963.
93. Yongseok Kwon, Alex J. Chinn, Byoungmoo Kim, Scott J. Miller. Divergent Control of Point and Axial Stereogenicity: Catalytic Enantioselective C−N Bond-Forming Cross-Coupling and Catalyst-Controlled Atroposelective Cyclodehydration. Angewandte Chemie International Edition 2018, 57 (21) , 6251-6255. DOI: 10.1002/anie.201802963.
94. Anne-Katrin Bachon, Anne-Dorothee Steinkamp, Carsten Bolm. N-Arylated Sulfoximines as Cross-Coupling Building Blocks. Advanced Synthesis & Catalysis 2018, 360 (6) , 1088-1093. DOI: 10.1002/adsc.201701394.
95. Serge Mignani, João Rodrigues, Helena Tomas, Rachid Jalal, Parvinder Pal Singh, Jean-Pierre Majoral, Ram A. Vishwakarma. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?. Drug Discovery Today 2018, 23 (3) , 605-615. DOI: 10.1016/j.drudis.2018.01.010.
96. Frank Lovering, Paul Morgan, Christophe Allais, Ann Aulabaugh, Joanne Brodfuehrer, Jeanne Chang, Jotham Coe, WeiDong Ding, Heather Dowty, Margaret Fleming, Richard Frisbie, Julia Guzova, David Hepworth, Jayasankar Jasti, Steve Kortum, Ravi Kurumbail, Shashi Mohan, Nikolaos Papaioannou, Joseph W. Strohbach, Fabien Vincent, Katherine Lee, Christoph W. Zapf. Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors. European Journal of Medicinal Chemistry 2018, 145, 606-621. DOI: 10.1016/j.ejmech.2017.12.041.
97. Mateo Berton, Lena Huck, Jesús Alcázar. On-demand synthesis of organozinc halides under continuous flow conditions. Nature Protocols 2018, 13 (2) , 324-334. DOI: 10.1038/nprot.2017.141.
98. Robert K. Orr, Jamie M. McCabe Dunn, Andrew Nolting, Alan M. Hyde, Eric R. Ashley, Joseph Leone, Eric Sirota, Jon A. Jurica, Andrew Gibson, Christopher Wise, Steven Oliver, Rebecca T. Ruck. New reactions and processes for the efficient synthesis of a HCV NS5b prodrug. Green Chemistry 2018, 20 (11) , 2519-2525. DOI: 10.1039/C8GC00102B.
99. Anthony Aimon, George Karageorgis, Jacob Masters, Mark Dow, Philip G. E. Craven, Martin Ohsten, Anthony Willaume, Rémy Morgentin, Nicolas Ruiz-Llamas, Hugues Lemoine, Tuomo Kalliokoski, Andrew J. Eatherton, Daniel J. Foley, Stephen P. Marsden, Adam Nelson. Realisation of small molecule libraries based on frameworks distantly related to natural products. Organic & Biomolecular Chemistry 2018, 16 (17) , 3160-3167. DOI: 10.1039/C8OB00688A.
100. Veronika Ručilová, Petra Králová, Miroslav Soural. Synthesis of Disubstituted Pyrazino-Oxazine Derivatives with Controlled Stereochemistry. European Journal of Organic Chemistry 2017, 2017 (47) , 7034-7039. DOI: 10.1002/ejoc.201701448.
101. Irini Abdiaj, Jesús Alcázar. Improving the throughput of batch photochemical reactions using flow: Dual photoredox and nickel catalysis in flow for C(sp2) C(sp3) cross-coupling. Bioorganic & Medicinal Chemistry 2017, 25 (23) , 6190-6196. DOI: 10.1016/j.bmc.2016.12.041.
102. Philippe Nuhant, Martins S. Oderinde, Julien Genovino, Antoine Juneau, Yohann Gagné, Christophe Allais, Gary M. Chinigo, Chulho Choi, Neal W. Sach, Louise Bernier, Yvette M. Fobian, Mark W. Bundesmann, Bhagyashree Khunte, Mathieu Frenette, Olugbeminiyi O. Fadeyi. Visible-Light-Initiated Manganese Catalysis for C−H Alkylation of Heteroarenes: Applications and Mechanistic Studies. Angewandte Chemie 2017, 129 (48) , 15511-15515. DOI: 10.1002/ange.201707958.
103. Philippe Nuhant, Martins S. Oderinde, Julien Genovino, Antoine Juneau, Yohann Gagné, Christophe Allais, Gary M. Chinigo, Chulho Choi, Neal W. Sach, Louise Bernier, Yvette M. Fobian, Mark W. Bundesmann, Bhagyashree Khunte, Mathieu Frenette, Olugbeminiyi O. Fadeyi. Visible-Light-Initiated Manganese Catalysis for C−H Alkylation of Heteroarenes: Applications and Mechanistic Studies. Angewandte Chemie International Edition 2017, 56 (48) , 15309-15313. DOI: 10.1002/anie.201707958.
104. Daniel J. Foley, Philip G. E. Craven, Patrick M. Collins, Richard G. Doveston, Anthony Aimon, Romain Talon, Ian Churcher, Frank von Delft, Stephen P. Marsden, Adam Nelson. Synthesis and Demonstration of the Biological Relevance of sp 3 -rich Scaffolds Distantly Related to Natural Product Frameworks. Chemistry - A European Journal 2017, 23 (60) , 15227-15232. DOI: 10.1002/chem.201704169.
105. Jesús Alcázar. Sustainable Flow Chemistry in Drug Discovery. 2017,,, 135-164. DOI: 10.1002/9783527689118.ch6.
106. Jaroslaw Polanski, Johann Gasteiger. Computer Representation of Chemical Compounds. 2017,,, 1997-2039. DOI: 10.1007/978-3-319-27282-5_50.
107. Jaroslaw Polanski. Big Data in Structure-Property Studies—From Definitions to Models. 2017,,, 529-552. DOI: 10.1007/978-3-319-56850-8_15.
108. F. Giordanetto, P. Jones, A. Nelson, J. Benningshof, G. Müller, A. Pannifer, S. van Boeckel, D. Tzalis. European Lead Factory. 2017,,, 505-519. DOI: 10.1016/B978-0-12-409547-2.12303-0.
109. Cecilia Saiz, Valentina Villamil, Mariano M. González, Ma. Agustina Rossi, Lorena Martínez, Leopoldo Suescun, Alejandro J. Vila, Graciela Mahler. Enantioselective synthesis of new oxazolidinylthiazolidines as enzyme inhibitors. Tetrahedron: Asymmetry 2017, 28 (1) , 110-117. DOI: 10.1016/j.tetasy.2016.11.002.
110. Chao-Ze Zhu, Jian-Jun Feng, Junliang Zhang. Rhodium-catalyzed intermolecular [3+3] cycloaddition of vinyl aziridines with C,N-cyclic azomethine imines: stereospecific synthesis of chiral fused tricyclic 1,2,4-hexahydrotriazines. Chemical Communications 2017, 53 (34) , 4688-4691. DOI: 10.1039/C7CC02078C.
111. Dominique Brossard, Pascal Retailleau, Vincent Dumontet, Philippe Breton, Sandy Desrat, Fanny Roussi. Fast & easy preparation of 3D scaffolds from methyl benzoate by a diversity oriented synthesis strategy based on Diels–Alder and ene-reactions. Organic & Biomolecular Chemistry 2017, 15 (26) , 5585-5592. DOI: 10.1039/C7OB01236E.
112. Daniel J. Foley, Adam Nelson, Stephen P. Marsden. Evaluierung neuer Reaktionen zur Steuerung der Wirkstoff-Forschung: ein Eignungstest. Angewandte Chemie 2016, 128 (44) , 13850-13857. DOI: 10.1002/ange.201604193.
113. Daniel J. Foley, Adam Nelson, Stephen P. Marsden. Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?. Angewandte Chemie International Edition 2016, 55 (44) , 13650-13657. DOI: 10.1002/anie.201604193.
114. Martin K. Bayliss, James Butler, Paul L. Feldman, Darren V.S. Green, Paul D. Leeson, Michael R. Palovich, Anthony J. Taylor. Quality guidelines for oral drug candidates: dose, solubility and lipophilicity. Drug Discovery Today 2016, 21 (10) , 1719-1727. DOI: 10.1016/j.drudis.2016.07.007.
115. Serge Mignani, Nabil El Brahmi, Saïd El Kazzouli, Laure Eloy, Delphine Courilleau, Joachim Caron, Mosto M. Bousmina, Anne-Marie Caminade, Thierry Cresteil, Jean-Pierre Majoral. A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action. European Journal of Medicinal Chemistry 2016, 122, 656-673. DOI: 10.1016/j.ejmech.2016.05.063.
116. Ibrahim Chaaban, El Sayeda M. El Khawass, Heba A. Abd El Razik, Nehad S. El Salamouni, Mariano Redondo-Horcajo, Isabel Barasoain, José Fernando Díaz, Jari Yli-Kauhaluoma, Vânia M. Moreira. Synthesis and Anti-Proliferative Activity of Sulfanyltriazolylnaphthalenols and Sulfanyltriazolylnaphthalene-1,4-diones. Archiv der Pharmazie 2016, 349 (9) , 749-761. DOI: 10.1002/ardp.201600134.
117. Jaroslaw Polanski, Urszula Kucia, Roksana Duszkiewicz, Agata Kurczyk, Tomasz Magdziarz, Johann Gasteiger. Molecular descriptor data explain market prices of a large commercial chemical compound library. Scientific Reports 2016, 6 (1) DOI: 10.1038/srep28521.
118. Jürgen Bajorath. Extending accessible chemical space for the identification of novel leads. Expert Opinion on Drug Discovery 2016, 11 (9) , 825-829. DOI: 10.1080/17460441.2016.1210126.
119. Nadia M. Ahmad. Solubility-driven lead optimisation: Recent examples and personal perspectives. Bioorganic & Medicinal Chemistry Letters 2016, 26 (13) , 2975-2979. DOI: 10.1016/j.bmcl.2016.04.049.
120. Paul D. Leeson. Molecular inflation, attrition and the rule of five. Advanced Drug Delivery Reviews 2016, 101, 22-33. DOI: 10.1016/j.addr.2016.01.018.
121. Jaroslaw Polanski, Jacek Bogocz, Aleksandra Tkocz. The analysis of the market success of FDA approvals by probing top 100 bestselling drugs. Journal of Computer-Aided Molecular Design 2016, 30 (5) , 381-389. DOI: 10.1007/s10822-016-9912-5.
122. Jonas Boström, Dean G. Brown. Stuck in a rut with old chemistry. Drug Discovery Today 2016, 21 (5) , 701-703. DOI: 10.1016/j.drudis.2016.02.017.
123. Jing Lu, Lei Chen, Jun Yin, Tao Huang, Yi Bi, Xiangyin Kong, Mingyue Zheng, Yu-Dong Cai. Identification of new candidate drugs for lung cancer using chemical–chemical interactions, chemical–protein interactions and a K-means clustering algorithm. Journal of Biomolecular Structure and Dynamics 2016, 34 (4) , 906-917. DOI: 10.1080/07391102.2015.1060161.
124. Serge Mignani, Scot Huber, Helena Tomás, João Rodrigues, Jean-Pierre Majoral. Compound high-quality criteria: a new vision to guide the development of drugs, current situation. Drug Discovery Today 2016, 21 (4) , 573-584. DOI: 10.1016/j.drudis.2016.01.005.
125. Justin Bower, Angelo Pugliese, Martin Drysdale. Strategies for Fragment Library Design. 2016,,, 99-118. DOI: 10.1002/9783527683604.ch05.
126. Frank Lovering, Cristina Aevazelis, Jeanne Chang, Christoph Dehnhardt, Lori Fitz, Seungil Han, Kristin Janz, Julie Lee, Neelu Kaila, Joseph McDonald, William Moore, Alessandro Moretto, Nikolaos Papaioannou, David Richard, Mark S. Ryan, Zhao-Kui Wan, Atli Thorarensen. Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP). ChemMedChem 2016, 11 (2) , 217-233. DOI: 10.1002/cmdc.201500333.
127. Natalia V. Povarova, Nina G. Bozhanova, Karen S. Sarkisyan, Roman Gritcenko, Mikhail S. Baranov, Ilia V. Yampolsky, Konstantin A. Lukyanov, Alexander S. Mishin. Docking-guided identification of protein hosts for GFP chromophore-like ligands. Journal of Materials Chemistry C 2016, 4 (14) , 3036-3040. DOI: 10.1039/C5TC03931B.
128. Megan H. Shaw, John F. Bower. Synthesis and applications of rhodacyclopentanones derived from C–C bond activation. Chemical Communications 2016, 52 (72) , 10817-10829. DOI: 10.1039/C6CC04359C.
129. Alexandria P. Taylor, Ralph P. Robinson, Yvette M. Fobian, David C. Blakemore, Lyn H. Jones, Olugbeminiyi Fadeyi. Modern advances in heterocyclic chemistry in drug discovery. Organic & Biomolecular Chemistry 2016, 14 (28) , 6611-6637. DOI: 10.1039/C6OB00936K.
130. Andrew J. S. Lin, Cecilia C. Russell, Jennifer R. Baker, Shelby L. Frailey, Jennette A. Sakoff, Adam McCluskey. A facile hybrid ‘flow and batch’ access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones. Organic & Biomolecular Chemistry 2016, 14 (37) , 8732-8742. DOI: 10.1039/C6OB01153E.
131. Pierre Regenass, Stéphanie Riché, Florent Péron, Didier Rognan, Marcel Hibert, Nicolas Girard, Dominique Bonnet. A step-economical multicomponent synthesis of 3D-shaped aza-diketopiperazines and their drug-like chemical space analysis. Organic & Biomolecular Chemistry 2016, 14 (37) , 8859-8863. DOI: 10.1039/C6OB01434H.
132. Helmut M. Hügel, Andrew T. Smith, Mark A. Rizzacasa. Macrolactam analogues of macrolide natural products. Organic & Biomolecular Chemistry 2016, 14 (48) , 11301-11316. DOI: 10.1039/C6OB02149B.
133. Kentaro Kawai, Yoshimasa Takahashi. In Silico Drug Design Using an Evolutionary Algorithm and Compound Database. YAKUGAKU ZASSHI 2016, 136 (1) , 107-112. DOI: 10.1248/yakushi.15-00230-3.
134. Jian-Jun Feng, Tao-Yan Lin, Hai-Hong Wu, Junliang Zhang. Modular Access to the Stereoisomers of Fused Bicyclic Azepines: Rhodium-Catalyzed Intramolecular Stereospecific Hetero-[5+2] Cycloaddition of Vinyl Aziridines and Alkenes. Angewandte Chemie 2015, 127 (52) , 16080-16084. DOI: 10.1002/ange.201509185.
135. Jian-Jun Feng, Tao-Yan Lin, Hai-Hong Wu, Junliang Zhang. Modular Access to the Stereoisomers of Fused Bicyclic Azepines: Rhodium-Catalyzed Intramolecular Stereospecific Hetero-[5+2] Cycloaddition of Vinyl Aziridines and Alkenes. Angewandte Chemie International Edition 2015, 54 (52) , 15854-15858. DOI: 10.1002/anie.201509185.
136. Fan-Shu Chen, Zhen-Ran Jiang. Prediction of drug’s Anatomical Therapeutic Chemical (ATC) code by integrating drug–domain network. Journal of Biomedical Informatics 2015, 58, 80-88. DOI: 10.1016/j.jbi.2015.09.016.
137. George Karageorgis, Mark Dow, Anthony Aimon, Stuart Warriner, Adam Nelson. Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists. Angewandte Chemie 2015, 127 (46) , 13742-13748. DOI: 10.1002/ange.201506944.
138. George Karageorgis, Mark Dow, Anthony Aimon, Stuart Warriner, Adam Nelson. Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists. Angewandte Chemie International Edition 2015, 54 (46) , 13538-13544. DOI: 10.1002/anie.201506944.
139. Hua Sun, Xiaotong Zhou, Baojian Wu. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells. Xenobiotica 2015, 45 (11) , 945-953. DOI: 10.3109/00498254.2015.1033502.
140. Peter Mbugua Njogu, Kelly Chibale. Current and Future Strategies for Improving Drug Discovery Efficiency. 2015,,, 287-328. DOI: 10.1002/9781118819586.ch11.
141. Christopher Kallus, Jörg Hüser, Philip S. Jones, Adam Nelson. The European Lead Factory. 2015,,, 37-60. DOI: 10.1002/9781118771723.ch2.
142. Pilar Ventosa-Andrés, Agustina La-Venia, Carlos Alfonso Barea Ripoll, Ludmila Hradilová, Viktor Krchňák. Synthesis of Nature-Inspired Medium-Sized Fused Heterocycles from Amino Acids. Chemistry - A European Journal 2015, 21 (37) , 13112-13119. DOI: 10.1002/chem.201501746.
143. György M. Keserü. Thermodynamics-Guided Optimizations in Medicinal Chemistry. 2015,,, 63-80. DOI: 10.1002/9783527673025.ch4.
144. Gary W Caldwell. In silico tools used for compound selection during target-based drug discovery and development. Expert Opinion on Drug Discovery 2015, 10 (8) , 901-923. DOI: 10.1517/17460441.2015.1043885.
145. Philip Craven, Anthony Aimon, Mark Dow, Nicolas Fleury-Bregeot, Rachel Guilleux, Remy Morgentin, Didier Roche, Tuomo Kalliokoski, Richard Foster, Stephen P. Marsden, Adam Nelson. Design, synthesis and decoration of molecular scaffolds for exploitation in the production of alkaloid-like libraries. Bioorganic & Medicinal Chemistry 2015, 23 (11) , 2629-2635. DOI: 10.1016/j.bmc.2014.12.048.
146. Thomas E. Storr, Sarah J. Cully, Michael J. Rawling, William Lewis, Daniel Hamza, Geraint Jones, Robert A. Stockman. Combining two-directional synthesis and tandem reactions. Part 21: Exploitation of a dimeric macrocycle for chain terminus differentiation and synthesis of an sp3-rich library. Bioorganic & Medicinal Chemistry 2015, 23 (11) , 2621-2628. DOI: 10.1016/j.bmc.2014.12.050.
147. Steve O′Hagan, Neil Swainston, Julia Handl, Douglas B. Kell. A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics 2015, 11 (2) , 323-339. DOI: 10.1007/s11306-014-0733-z.
148. Brecht Egle, Juan Muñoz, Nerea Alonso, Wim De Borggraeve, Antonio de la Hoz, Angel Díaz-Ortiz, Jesús Alcázar. First Example of Alkyl–Aryl Negishi Cross-Coupling in Flow: Mild, Efficient and Clean Introduction of Functionalized Alkyl Groups. Journal of Flow Chemistry 2015, 4 (1) , 22-25. DOI: 10.1556/JFC-D-13-00009.
149. Elizabeth Kwong. Advancing Drug Discovery: A Pharmaceutics Perspective. Journal of Pharmaceutical Sciences 2015, 104 (3) , 865-871. DOI: 10.1002/jps.24294.
150. Eugen F. Mesaros, Thelma S. Angeles, Mark S. Albom, Jason C. Wagner, Lisa D. Aimone, Weihua Wan, Lihui Lu, Zeqi Huang, Mark Olsen, Emily Kordwitz, R. Curtis Haltiwanger, Amy J. Landis, Mangeng Cheng, Bruce A. Ruggeri, Mark A. Ator, Bruce D. Dorsey, Gregory R. Ott. Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase. Bioorganic & Medicinal Chemistry Letters 2015, 25 (5) , 1047-1052. DOI: 10.1016/j.bmcl.2015.01.019.
151. Gong-Feng Zou, Zhi-Peng Hu, Shi-Qiang Zhang, Wei-Wei Liao. Synthesis of functionalized 1,2-dihydropyridines bearing quaternary carbon centers via an organocatalytic allylic alkylation. Tetrahedron Letters 2015, 56 (7) , 937-940. DOI: 10.1016/j.tetlet.2014.12.116.
152. C. Rademacher, P. H. Seeberger. High-Throughput Synthesis of Diverse Compound Collections for Lead Discovery and Optimization. 2015,,, 73-89. DOI: 10.1007/164_2015_25.
153. Jaroslaw Polanski, Johann Gasteiger. Computer Representation of Chemical Compounds. 2015,,, 1-43. DOI: 10.1007/978-94-007-6169-8_50-1.
154. Hongming Chen, Ola Engkvist, Thierry Kogej. Compound Properties and their Influence on Drug Quality. 2015,,, 379-393. DOI: 10.1016/B978-0-12-417205-0.00015-8.
155. Weston J. Umstead, Olga A. Mukhina, N. N. Bhuvan Kumar, Andrei G. Kutateladze. Photoinduced Cycloadditions in the Diversity-Oriented Synthesis Toolbox: Increasing Complexity with Straightforward Post-Photochemical Modifications. Australian Journal of Chemistry 2015, 68 (11) , 1672. DOI: 10.1071/CH15266.
156. Nerea Alonso, L. Zane Miller, Juan de M. Muñoz, Jesus Alcázar, D. Tyler McQuade. Continuous Synthesis of Organozinc Halides Coupled to Negishi Reactions. Advanced Synthesis & Catalysis 2014, 356 (18) , 3737-3741. DOI: 10.1002/adsc.201400243.
157. George Karageorgis, Stuart Warriner, Adam Nelson. Efficient discovery of bioactive scaffolds by activity-directed synthesis. Nature Chemistry 2014, 6 (10) , 872-876. DOI: 10.1038/nchem.2034.
158. Amrit Paudel, Marco Geppi, Guy Van den Mooter. Structural and Dynamic Properties of Amorphous Solid Dispersions: The Role of Solid-State Nuclear Magnetic Resonance Spectroscopy and Relaxometry. Journal of Pharmaceutical Sciences 2014, 103 (9) , 2635-2662. DOI: 10.1002/jps.23966.
159. C Guillemette, É Lévesque, M Rouleau. Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications. Clinical Pharmacology & Therapeutics 2014, 96 (3) , 324-339. DOI: 10.1038/clpt.2014.126.
160. K. C. Nicolaou. Advancing the Drug Discovery and Development Process. Angewandte Chemie 2014, 126 (35) , 9280-9292. DOI: 10.1002/ange.201404761.
161. K. C. Nicolaou. Advancing the Drug Discovery and Development Process. Angewandte Chemie International Edition 2014, 53 (35) , 9128-9140. DOI: 10.1002/anie.201404761.
162. Mingfei Ji, Xubo Su, Xiaohong Su, Yingyi Chen, Wenkang Huang, Jian Zhang, Zhaobin Gao, Chuangang Li, Xuefeng Lu. Identification of Novel Compounds for Human Bitter Taste Receptors. Chemical Biology & Drug Design 2014, 84 (1) , 63-74. DOI: 10.1111/cbdd.12293.
163. Patrick Augustijns, Benjamin Wuyts, Bart Hens, Pieter Annaert, James Butler, Joachim Brouwers. A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption. European Journal of Pharmaceutical Sciences 2014, 57, 322-332. DOI: 10.1016/j.ejps.2013.08.027.
164. Simon Duttwyler, Shuming Chen, Colin Lu, Brandon Q. Mercado, Robert G. Bergman, Jonathan A. Ellman. Regio- and Stereoselective 1,2-Dihydropyridine Alkylation/Addition Sequence for the Synthesis of Piperidines with Quaternary Centers. Angewandte Chemie 2014, 126 (15) , 3958-3961. DOI: 10.1002/ange.201310517.
165. Simon Duttwyler, Shuming Chen, Colin Lu, Brandon Q. Mercado, Robert G. Bergman, Jonathan A. Ellman. Regio- and Stereoselective 1,2-Dihydropyridine Alkylation/Addition Sequence for the Synthesis of Piperidines with Quaternary Centers. Angewandte Chemie International Edition 2014, 53 (15) , 3877-3880. DOI: 10.1002/anie.201310517.
166. Dong Xiao, Xiaohong Zhu, Younong Yu, Ning Shao, Jie Wu, Kevin D. McCormick, Pawan Dhondi, Jun Qin, Robert Mazzola, Haiqun Tang, Ashwin Rao, Phieng Siliphaivanh, Hongchen Qiu, Xiaoxin Yang, Maria Rivelli, Charles G. Garlisi, Steve Eckel, Gitali Mukhopadhyay, Craig Correll, Diane Rindgen, Robert Aslanian, Anandan Palani. Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties. Bioorganic & Medicinal Chemistry Letters 2014, 24 (6) , 1615-1620. DOI: 10.1016/j.bmcl.2014.01.043.
167. Jing Lu, Guohua Huang, Hai-Peng Li, Kai-Yan Feng, Lei Chen, Ming-Yue Zheng, Yu-Dong Cai, . Prediction of Cancer Drugs by Chemical-Chemical Interactions. PLoS ONE 2014, 9 (2) , e87791. DOI: 10.1371/journal.pone.0087791.
168. Guillermo M. Chans, E. Laura Moyano, María Teresa Baumgartner. NMR and computational studies on tautomerism of 3-hydroxy-2-(2-thienylcarbonyl)cyclohex-2-en-1-one. Journal of Molecular Structure 2014, 1059, 176-184. DOI: 10.1016/j.molstruc.2013.11.057.
169. Andrew L. Hopkins, György M. Keserü, Paul D. Leeson, David C. Rees, Charles H. Reynolds. The role of ligand efficiency metrics in drug discovery. Nature Reviews Drug Discovery 2014, 13 (2) , 105-121. DOI: 10.1038/nrd4163.
170. Ryan J. Rafferty, Robert W. Hicklin, Katherine A. Maloof, Paul J. Hergenrother. Synthesis of Complex and Diverse Compounds through Ring Distortion of Abietic Acid. Angewandte Chemie 2014, 126 (1) , 224-228. DOI: 10.1002/ange.201308743.
171. Ryan J. Rafferty, Robert W. Hicklin, Katherine A. Maloof, Paul J. Hergenrother. Synthesis of Complex and Diverse Compounds through Ring Distortion of Abietic Acid. Angewandte Chemie International Edition 2014, 53 (1) , 220-224. DOI: 10.1002/anie.201308743.
172. Antonio de la Vega de León, Jürgen Bajorath. Matched molecular pairs derived by retrosynthetic fragmentation. Med. Chem. Commun. 2014, 5 (1) , 64-67. DOI: 10.1039/C3MD00259D.
173. V. Zohrabi-Kalantari, F. Wilde, R. Grünert, P. J. Bednarski, A. Link. 4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of a screening library. MedChemComm 2014, 5 (2) , 203. DOI: 10.1039/c3md00252g.
174. Hasnain A. Malik, Buck L. H. Taylor, John R. Kerrigan, Jonathan E. Grob, K. N. Houk, J. Du Bois, Lawrence G. Hamann, Andrew W. Patterson. Non-directed allylic C–H acetoxylation in the presence of Lewis basic heterocycles. Chemical Science 2014, 5 (6) , 2352. DOI: 10.1039/c3sc53414f.
175. Ying-Ting Lin. A tandem regression-outlier analysis of a ligand cellular system for key structural modifications around ligand binding. Journal of Cheminformatics 2013, 5 (1) DOI: 10.1186/1758-2946-5-21.
176. Francesco Napolitano, Yan Zhao, Vânia M Moreira, Roberto Tagliaferri, Juha Kere, Mauro D’Amato, Dario Greco. Drug repositioning: a machine-learning approach through data integration. Journal of Cheminformatics 2013, 5 (1) DOI: 10.1186/1758-2946-5-30.
177. Lamees Hegazy, Nigel G. J. Richards. Optimized CGenFF force-field parameters for acylphosphate and N-phosphonosulfonimidoyl functional groups. Journal of Molecular Modeling 2013, 19 (11) , 5075-5087. DOI: 10.1007/s00894-013-1990-x.
178. Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, Sorel Muresan, . Tracking 20 Years of Compound-to-Target Output from Literature and Patents. PLoS ONE 2013, 8 (10) , e77142. DOI: 10.1371/journal.pone.0077142.
179. Stéphanie Vandekerckhove, Hai Giang Tran, Tom Desmet, Matthias D’hooghe. Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents. Bioorganic & Medicinal Chemistry Letters 2013, 23 (16) , 4641-4643. DOI: 10.1016/j.bmcl.2013.06.014.
180. José Luis Medina-Franco. Chemoinformatic Characterization of the Chemical Space and Molecular Diversity of Compound Libraries. 2013,,, 325-352. DOI: 10.1002/9781118618110.ch10.
181. Andrew Rowland, John O. Miners, Peter I. Mackenzie. The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification. The International Journal of Biochemistry & Cell Biology 2013, 45 (6) , 1121-1132. DOI: 10.1016/j.biocel.2013.02.019.
182. Mounir Andaloussi, Herman D. Lim, Tiffany van der Meer, Maarten Sijm, Chris B.M. Poulie, Iwan J.P. de Esch, Rob Leurs, Rogier A. Smits. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787. Bioorganic & Medicinal Chemistry Letters 2013, 23 (9) , 2663-2670. DOI: 10.1016/j.bmcl.2013.02.091.
183. Amrit Paudel, Yves Loyson, Guy Van den Mooter. An Investigation into the Effect of Spray Drying Temperature and Atomizing Conditions on Miscibility, Physical Stability, and Performance of Naproxen–PVP K 25 Solid Dispersions. Journal of Pharmaceutical Sciences 2013, 102 (4) , 1249-1267. DOI: 10.1002/jps.23459.
184. Robert W. Huigens III, Karen C. Morrison, Robert W. Hicklin, Timothy A. Flood Jr, Michelle F. Richter, Paul J. Hergenrother. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nature Chemistry 2013, 5 (3) , 195-202. DOI: 10.1038/nchem.1549.
185. S. Duttwyler, S. Chen, M. K. Takase, K. B. Wiberg, R. G. Bergman, J. A. Ellman. Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis. Science 2013, 339 (6120) , 678-682. DOI: 10.1126/science.1230704.
186. Klaus Mohr, Jens Schmitz, Ramona Schrage, Christian Tränkle, Ulrike Holzgrabe. Molekulare Allianz - von orthosterischen und allosterischen Liganden zu dualsterischen/bitopischen Agonisten G-Protein-gekoppelter Rezeptoren. Angewandte Chemie 2013, 125 (2) , 530-538. DOI: 10.1002/ange.201205315.
187. Klaus Mohr, Jens Schmitz, Ramona Schrage, Christian Tränkle, Ulrike Holzgrabe. Molecular Alliance-From Orthosteric and Allosteric Ligands to Dualsteric/Bitopic Agonists at G Protein Coupled Receptors. Angewandte Chemie International Edition 2013, 52 (2) , 508-516. DOI: 10.1002/anie.201205315.
188. Elke Socher, Tom N. Grossmann. Chemical Biology 2012: From Drug Targets to Biological Systems and Back. ChemBioChem 2013, 14 (1) , 23-27. DOI: 10.1002/cbic.201200697.
189. Sandrine Vendeville, Maxwell D. Cummings. Synthetic Macrocycles in Small-Molecule Drug Discovery. 2013,,, 371-386. DOI: 10.1016/B978-0-12-417150-3.00023-5.
190. Frank Lovering. Escape from Flatland 2: complexity and promiscuity. MedChemComm 2013, 4 (3) , 515. DOI: 10.1039/c2md20347b.
191. Elise M. Rochette, William Lewis, Al G. Dossetter, Robert A. Stockman. Highly diastereoselective radical cyclisations of chiral sulfinimines. Chemical Communications 2013, 49 (82) , 9395. DOI: 10.1039/c3cc45452e.
192. Timothy J. Ritchie, Simon J. F. Macdonald, Simon Peace, Stephen D. Pickett, Christopher N. Luscombe. Increasing small molecule drug developability in sub-optimal chemical space. MedChemComm 2013, 4 (4) , 673. DOI: 10.1039/c3md00003f.
193. Claire Coderch, Yong Tang, Javier Klett, Shu-En Zhang, Yun-Tao Ma, Wang Shaorong, Ruth Matesanz, Benet Pera, Angeles Canales, Jesús Jiménez-Barbero, Antonio Morreale, J. Fernando Díaz, Wei-Shuo Fang, Federico Gago. A structure-based design of new C2- and C13-substituted taxanes: tubulin binding affinities and extended quantitative structure–activity relationships using comparative binding energy (COMBINE) analysis. Organic & Biomolecular Chemistry 2013, 11 (18) , 3046. DOI: 10.1039/c3ob40407b.
194. Peter S. Kutchukian, Nadya Y. Vasilyeva, Jordan Xu, Mika K. Lindvall, Michael P. Dillon, Meir Glick, John D. Coley, Natasja Brooijmans, . Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery. PLoS ONE 2012, 7 (11) , e48476. DOI: 10.1371/journal.pone.0048476.
195. Susan M. Boyd, Andrew P. Turnbull, Björn Walse. Fragment library design considerations. Wiley Interdisciplinary Reviews: Computational Molecular Science 2012, 2 (6) , 868-885. DOI: 10.1002/wcms.1098.
196. Dmitry Genis, Mikhail Kirpichenok, Roman Kombarov. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds. Drug Discovery Today 2012, 17 (21-22) , 1170-1174. DOI: 10.1016/j.drudis.2012.05.013.
197. . Introduction. 2012,,, 1-8. DOI: 10.1002/9781118407738.ch1.
198. . Mechanism of Drug Action: Basic Concepts. 2012,,, 9-38. DOI: 10.1002/9781118407738.ch2.
199. . The Drug Discovery and Development Process. 2012,,, 39-70. DOI: 10.1002/9781118407738.ch3.
200. John A Arnott, Sonia Lobo Planey. The influence of lipophilicity in drug discovery and design. Expert Opinion on Drug Discovery 2012, 7 (10) , 863-875. DOI: 10.1517/17460441.2012.714363.
201. William A. Nugent. Black-Swan-Ereignisse in der organischen Synthese. Angewandte Chemie 2012, 124 (36) , 9066-9080. DOI: 10.1002/ange.201202348.
202. William A. Nugent. “Black Swan Events” in Organic Synthesis. Angewandte Chemie International Edition 2012, 51 (36) , 8936-8949. DOI: 10.1002/anie.201202348.
203. Neha K Grewal, Nicholas E Leadbeater. The central role of chemistry in ‘quality by design’ approaches to drug development. Future Medicinal Chemistry 2012, 4 (14) , 1799-1810. DOI: 10.4155/fmc.12.117.
204. Sridhar Aravapalli, Huiguo Lai, Tadahisa Teramoto, Kevin R. Alliston, Gerald H. Lushington, Eron L. Ferguson, R. Padmanabhan, William C. Groutas. Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. Bioorganic & Medicinal Chemistry 2012, 20 (13) , 4140-4148. DOI: 10.1016/j.bmc.2012.04.055.
205. Craig Johnstone. Medicinal chemistry matters – a call for discipline in our discipline. Drug Discovery Today 2012, 17 (11-12) , 538-543. DOI: 10.1016/j.drudis.2012.01.010.
206. David R Janero. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca. Expert Opinion on Drug Discovery 2012, 7 (6) , 449-456. DOI: 10.1517/17460441.2012.685154.
207. Maxwell D. Cummings, Tse-I Lin, Lili Hu, Abdellah Tahri, David McGowan, Katie Amssoms, Stefaan Last, Benoit Devogelaere, Marie-Claude Rouan, Leen Vijgen, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Erna Cleiren, Liesbet van der Helm, Gregory Fanning, Kristof Van Emelen, Origène Nyanguile, Kenny Simmen, Pierre Raboisson, Sandrine Vendeville. Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. Angewandte Chemie 2012, 124 (19) , 4715-4718. DOI: 10.1002/ange.201200110.
208. Maxwell D. Cummings, Tse-I Lin, Lili Hu, Abdellah Tahri, David McGowan, Katie Amssoms, Stefaan Last, Benoit Devogelaere, Marie-Claude Rouan, Leen Vijgen, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Erna Cleiren, Liesbet van der Helm, Gregory Fanning, Kristof Van Emelen, Origène Nyanguile, Kenny Simmen, Pierre Raboisson, Sandrine Vendeville. Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. Angewandte Chemie International Edition 2012, 51 (19) , 4637-4640. DOI: 10.1002/anie.201200110.
209. Alfonso T. García-Sosa, Mare Oja, Csaba Hetényi, Uko Maran. Disease-Specific Differentiation Between Drugs and Non-Drugs Using Principal Component Analysis of Their Molecular Descriptor Space. Molecular Informatics 2012, 31 (5) , 369-383. DOI: 10.1002/minf.201100094.
210. Michael M. Hann, György M. Keserü. Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nature Reviews Drug Discovery 2012, 11 (5) , 355-365. DOI: 10.1038/nrd3701.
211. Romualdo Benigni. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?. Expert Opinion on Drug Metabolism & Toxicology 2012, 8 (4) , 407-417. DOI: 10.1517/17425255.2012.666238.
212. Adele Faulkner, John F. Bower. Highly Efficient Narasaka-Heck Cyclizations Mediated by P(3,5-(CF3)2C6H3)3: Facile Access to N-Heterobicyclic Scaffolds. Angewandte Chemie 2012, 124 (7) , 1707-1711. DOI: 10.1002/ange.201107511.
213. Adele Faulkner, John F. Bower. Highly Efficient Narasaka-Heck Cyclizations Mediated by P(3,5-(CF3)2C6H3)3: Facile Access to N-Heterobicyclic Scaffolds. Angewandte Chemie International Edition 2012, 51 (7) , 1675-1679. DOI: 10.1002/anie.201107511.
214. W Patrick Walters. Going further than Lipinski's rule in drug design. Expert Opinion on Drug Discovery 2012, 7 (2) , 99-107. DOI: 10.1517/17460441.2012.648612.
215. Michael D. Wendt. Protein-Protein Interactions as Drug Targets. 2012,,, 1-55. DOI: 10.1007/978-3-642-28965-1_1.
216. David W. Borhani, David E. Shaw. The future of molecular dynamics simulations in drug discovery. Journal of Computer-Aided Molecular Design 2012, 26 (1) , 15-26. DOI: 10.1007/s10822-011-9517-y.
217. Hongming Chen, Ola Engkvist, Niklas Blomberg, Jin Li. A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds. Med. Chem. Commun. 2012, 3 (3) , 312-321. DOI: 10.1039/C2MD00238H.
218. Tetyana Petrova, Alexander Chuprina, Raman Parkesh, Alexei Pushechnikov. Structural enrichment of HTS compounds from available commercial libraries. MedChemComm 2012, 3 (5) , 571. DOI: 10.1039/c2md00302c.